|
RECOMMENDED CONCISE
|
Bad Choices, Pharma
|
|
|
A second portion of this article is "Bad Choices" with concise recommendations on Aspirin, natural estrogen
(estradiol), Q10, testosterone, and the niacin and other cholesterol lowering agents. http://healthfully.org/rc/id14.html
Two Changes
in content coming up
The cholesterol myth.
Numerous critics have pointed out that cardiovascular
disease is not caused by higher levels of blood cholesterol or fats. Pharma
promotes the cholesterol myth and
ignores the major causes. Major cause of cardiovascular
disease is
pathogens living within the middle layer of artery walls. It initiates the immune
response which involves
LDL, HDL, and white blood cells.
Reactive chemicals such as simple sugars and carbon monoxide can
potentiate the process resulting in the formation of plaque within the artery
walls.
For confirmation from journal articles
on primary role of
infective agent enter into http://scholar.google.com/
terms such as bacteria + atherosclerosis
or go to http://healthfully.org/rl/id8.html
and id9 for
collection of articles
For confirmation of cholesterol myth enter into http://scholar.google.com/ or http://www.amazon.com/ cholesterol myth, or go to http://healthfully.org/rl/id5.html
for collection of journal articles
Pharma treatments
summarized with healthful alternatives
Subsection
coronary vascular issues
Heart issues: The biological process leading to cardiovascular disease explains (1) why
pharma’s drugs are not effective (once their side effects and costs are
included in the calculations); and (2) why the prevention of hardening of the
arties is the best approach. Hardening
of the arteries is caused by an inflammatory by lymphocytes which causes a scavenger
response by macrophages to engulf the oxidative damaged LDL (low density
lipoproteins, bad cholesterol). The
macrophages die and form foam cells which constitute most of the plaque in hardening
of the arteries. As the load of plaque
accumulates and ages it causes cardiovascular
disease (CVD), which makes the
arteries stiff and occluded and this
causes high blood pressure. When the
plaque breaks off, a thrombosis can result, and when it occurs in the coronary
artery it can cause a heart attack, and in
the brain a strokes (acute events), Acute events are only moderately
associated with high levels of LDL. LDL causes
CVD only when it undergoes oxidative
damage. The principle cause for oxidative damage of
LDL is carbon monoxide (found in smoke) and other blood-borne reactive
chemicals. The more LDL, the more
targets for reactive chemicals and thus a faster the rate of formation of
plaque. However, over 85% of acute
events are caused by young, unstable
plaque (not old hard) that leaks, when the plaque occlusion is from 20% to
50%—young plaque is not encapsulated. Thus
about 20% of heart attacks occur in those without the signs of CVD: high blood
pressure, angina, or high levels
of cholesterol. Another factor
is chronic inflammation (such
as by gingivitis of the gums and pylori bacteria in the stomach). It is estimated
that about 1/6th
of all heart attacks and strokes are caused by chronic inflammation. The common
type of heart attack results when plaque
breaks loose in the coronary artery and form a partial plugs down-stream, and
then a clot forms to totally occlude the coronary artery. Blood turbulence increases
with the occlusion
caused by the plaque plug which can result in a clot forming. High blood pressure
increases the turbulence and
thus the likeliness that a clot will form.
That is why high blood pressure is a causal factor for a heart
attack. A like process can happen
in the brain, a
stroke. The best
treatments is to prevent hardening of the arteries starting early in life,
and thus less plaque and normal blood pressure. This is best accomplished by 1)
healthful lifestyle including avoiding carbon monoxide, 2) inhibiting oxidative
damage to LDL and 3) inhibiting the inflammation
response of white blood cells to damaged LDL. Lowering LDL when it is high
is far less
effective way to prevent hardening of the arteries—for which doctors prescribe
statins. For one thing, high LDL might
not occur until after there is a large amount of plaque in the arteries. Clearly
the best drugs are 325 mg aspirin,
300 mg Q10, and natural estrogen post-menopause, or
testosterone past the age of
70 . These choices are much better than
statins and blood pressure drugs (see below).
If these were taken by teenagers and continued throughout life, pharma’s
income would eventually be cut in half.
Pharma thus teaches that aspirin, estrogen,
and testosterone pose major health risks that outweigh their coronary benefits,
and they ignore their other benefit of them and Q10. And all this is supported
by their tobacco
science, which is taught to doctors in their continuing education classes and pushed
through treatment guidelines. Pharma
also teaches doctors that high blood pressure and high levels of LDL cause CVD
in order to promote their sales of
drugs that treat these health issues, for which they make billions. Their mantra
is “safe and effective.”
Anticoagulants (blood thinners): They are widely prescribed to
prevent or treat thrombosis (blood
clots), which can damage the brain (stroke), heart (myocardial infarction),
lung (pulmonary embolism), and other organs.
They are commonly given to those who undergo major surgery, are
hospitalized for 3 days and longer, or have arrhythmia (irregular heart beat)
because of their higher risk of thrombosis.
With a few exceptions, they aren’t worth the side effects. Pharma
exaggerates the risks and benefits;
their sales mantra is “safe and effective”.
Once out of the hospital this treatment is normally continued. They aren’t
worth the side effects. A much, much better choice is to take a 325
mg of aspirin in the morning and another in the evening, and it has many other
health benefits (see aspirin above). At
this higher dose it is a better long-term anticoagulant for preventing heart
attacks and strokes (by about 50%), and it lowers the risk of most cancer overs
40%. Cardio-exercise and weight control
offer significant benefits because a poor flow of blood is the major causal
factor, and it lowers blood pressure another causal factor for blood clots.
Arrhythmia (irregular heartbeat):
is
any of a large and heterogeneous group of
conditions in which there is abnormal electrical
[nerve] activity in the heart. Although
many arrhythmias are not
life-threatening, some can cause sudden death.
Most such sudden deaths occur during a major heart attack due to the
destruction of heart muscle. A basic
problem with treating an irregular
heart beat with drugs is that they are not magic bullets that just work upon
the cardiac nerves. They inhibit
neurotransmitters; thus upset cognitive and bodily functions. Arrhythmia
is a disease of mostly
seniors, and most drugs are on the American Geriatric Society’s avoid
list. Moreover, they don’t
stop arrhythmia (just modestly reduce them short
term) and can cause pro-arrhythmia (drug induced
arrhythmia), and they have at best minimal
effect upon death. Other treatments include physical maneuvers,
electricity conversion, and electro or cryocautery. Just like drugs, the merits
of these physical
interventions are oversold.
Hardening of the arteries
(atherosclerosis, cardiovascular disease): Aspirin and Q10 are
the best first line of defense and
should be taken daily starting in the teen years (see Q10 and aspirin). In addition
women starting with menopause and
continuing thereafter should take the natural estrogen (estradiol), and men
starting between 60 and 75 should take testosterone. There is major cardiovascular
protection with
estradiol; it is why cardiovascular disease and heart attacks occur following
menopause. Men on testosterone are less likely to develop metabolic syndrome
(diabetes, hypertension, and atherosclerosis) and are more likely to survive a
heart attack. Cardiovascular disease
results from oxidative damage to LDL and VDL
(the bad cholesterols) that stimulates an inflammatory response in macrophages. They
also ingest the damaged LDL and become
foam cells that become part of the plaque, and this sequence of events causes
plaque formation. Macrophages are a type
of white blood cell that scavenges damage cells, and also oxidative damaged
LDL. Estrogen and Q10 protect LDL and
VDL from oxidative damage, and aspirin and estrogen inhibit the inflammatory
process. As for statins:
pharma hypes its benefit and hides their side effects. (See section below
as to their failure to
reduce mortality though they lower LDL.)
Once hardening of the arteries occurs, since the plaque is encapsulated,
it is beyond the reach of drugs. Aspirin,
estradiol, and Q10 along with healthful lifestyle can stop the formation of new
plaque, and in most cases over the years there will be a gradual improvement
through revascularization.
Heart Attacks (MI) and
treatments: “Each year
[2005] 1.5 million Americans experience a heart attack and nearly 460,000 are
fatal. Of those who die, almost half die
suddenly, before they can get to a hospital” AHA. As with most acute conditions the list
of
standard treatments, most are not worth the side effects. Following the
list below when the patient is
depending upon the help requires making the doctor aware of who is the ultimate
decider. With MI, there are two phases
acute and recovery. For recovery the typical
well insured patient is treated long-term for a variety of issues that cost on
an average over $70,000 per year. Nearly
all of them have better alternatives. CRITICAL
CARE AVOID: (in order of importance):
downers (psychotropic drug), Protein
Pump Inhibitor (PPI), heparin & other blood
thinners, high blood pressure medication
except if extreme 180 over 110, antiarrhythmics
except for lidocaine, and oxygen. Downers
(psychotropic drugs) have many
indications such as anti-nauseas, muscle relaxant, sedative. If drowsiness or
mental confusion is a side effect, it is probably a downer (or an opiate). Drugged,
the patient is less likely to inform
the nurse of a negative turn in their condition, or resist their doctor’s
advice. PPIs for acid indigestion are
addicting. Instead of heparin or similar
anticoagulant promptly take 975 mgs aspirin, followed by one every 4
hours. Drugs for hypertension other than
nitroglycerin do not lower morality Cochrane
Library and many of them are
downers. RECOVERY AVOID: PPI
is given with the anticoagulant, but PPIs
are addicting because of the rebound effect, and long-term usage
causes serious life-shortening, side effects such as osteoporosis &
colitis. Tums, when needed, is a better
choice. Statins are totally over sold,
and are justified only by marketing
science. Counter to their marketing
science, they are not cardiovascular protective through they improved the lipid
profile and thus are not worth the side effects. PPI,
statin, blood pressure drugs, blood thinner, antiarrhythmics drug therapy, and
downer lack quality evidence that proves their net worth and superiority
to other choices; yet
they are routinely administered in the hospital and nursing home, when the
patient is most vulnerable. Avoid polypharmacy because it multiplies the risk of major
side effects. All too often their side effects are treated
with additional drugs. All side
effects are grossly under-reported. Most
drugs started in the hospital and
nursing home will be continued long-term.
While recovering, avoid both stent and
bypass operation, they do not prolong significantly life, though they
reduce angina pain. “The vast majority of MIs do not originate with obstructions that
narrow arteries" Wiki. An exception would for acute STEMI with
unstable refractory angina with objective evidence of ischemia, UK study.
The best choice is to follow the recommendations in the section on Niacin
below.
Hypertension: First choice is Q10 (300 mgs),
exercise, sodium restriction, and weight control. Over half of those who follow
this program
will have normal blood by 1 year.
Moreover, the prestigious Cochrane review concluded that: “Drugs for mild hypertension have not
been proven to benefit patients.” Mild
hypertension is a systolic 140-159 and diastolic 90-99. If after 2 year there
isn’t sufficient
progress at lowering blood pressure below 160 over 100, then the second choice is “thiazide and thiazide-like
diuretics [lowers the
amount of water in the body]. [They]
have good evidence of beneficial effects on important endpoints of hypertension … [and
they] also
increase calcium re-absorption at the distal tubule” Wiki, and they
are among the cheapest drugs. They are
widely recommended as first line in treatment guidelines. Treating hypertension
with pharma’s drug
arsenal (over 100 drugs of which 3 are typically prescribed at one time) has
serious side effects including drowsiness, cognitive impairment, ED, and low
libido. Moreover, pharma’s régime of
drugs when taken long-term doesn’t extend life.
For example the very popular group of calcium channel blockers cause a
“higher mortality rate over extended periods of use” Wiki. The first approach (Q10, diet, etc) is the
only reasonable choice. Long term
prevention of further development of hardening of the arteries through aspirin
325 mgs, Q10, and estrogen will in most cases result in a gradual lowering of
blood pressure, and a significant long-term reduction in mortality.
Statins and cholesterol:
Cardiovascular disease (CVD)
results from oxidative damage to LDL and VDL (the bad cholesterols) that
stimulates an inflammatory in T-lymphocytes which then causes macrophages to engulf
the oxidized LDL. This result in the
formation of foam cells (dead macrophages), which constitute most of plaque. Macrophages
are a type of white blood cell
that scavenges damage cells and oxidative damaged LDL. A lower level of cholesterol entail that there is less LDL to
be damage by reactive chemicals, the most significant being carbon monoxide--a
product of incomplete combustion. Thus
some of the carbon monoxide will react with other molecules. Thus lower level
of cholesterol only has a
modest effect upon plaque formation. For
a complex set of reasons, statins positive effect of lowering cholesterol is
undone by its promotion of oxidative damage through inhibition of COX enzymes
and its slowing the process of converting unstable to stable plaque. Statins
don’t protect against coronary artery
disease and its deadly consequences.
Several large proper scientific studies have failed to find significant
health benefits—though of course there are marketing studies that produce
positive results. Statins side effects
(especially its negative effects upon
cognitive function, sexual activity, and physical energy) make it not worth
taking. Pharma, as is their norm, has
done marketing studies to show that statins are safe and effective. That 90%
of doctors believe that statins are
safe and effective is testimony to the effectiveness of pharma’s use of
continuing education to promote sales.
Moreover, those above 70 years and those with congestive heart failure definitely
should not take statins, a
fact that most doctors are not aware of.
The critics lack an effective forum to affect medical practice. Only
those with a familial genetic defect
that causes cholesterol levels that are twice the norm should be on statins,
which is what the first statin was approved for. For
high cholesterol the best choices are Q10 300 mg, which prevents oxidative
damage to LDL, aspirin 325 twice daily, which lowers the inflammatory response
of macrophages, and estradiol 4 mg (the best of the 4 natural estrogens) and
testosterone 100 mg. These hormones
lower the risk for CVD, metabolic syndrome, and the resultant much higher rates
for heart attacks and strokes. Estrogen
is significantly more effective than testosterone. Best source for hormones
is a compounding
pharmacy.
|
|
AVOID LIST --6/23/14
With position papers: acetaminophen, chemotherapy
for cancer
(with a few exceptions).
Other Drugs: bisphosphonates for osteoporosis, psychotropic drugs (downers),
Alzheimer’s disease, protein pump inhibitors for heart burn.
A separate paper here sets out the cholesterol myth and the ineffective treatments for high blood
pressure, high cholesterol, irregular heartbeat, and blood clots, with a list
of much better alternatives. The article
on the role of diet in chronic conditions contains a list of foods to avoid. There
are links to the longer articles. For Cardiovascular
Disease and drugs.
Drugs with
position papers:
Acetaminophen (Paracetamol,
APAP): It
is the most widely
sold over-the-counter drug for the relief of pain[1],
fever, and headaches. It is found in
over a 100 over-the-counter and prescription preparation (mostly opiates). As
a mild analgesic APAP’s inclusion with an
opiate cannot be justified given its severe side effect of causing live
damage. The annual
percentage of potentially fatal acute liver failure (ALF) hospitalizations
caused by acetaminophen rose from 28 percent in 1998 to 51 percent in 2003. A
major cause is that acetaminophen is
indicated as APAP on most opiate prescriptions and the common use of the
over-the-counter Tylenol as a second drug for relieve of pain. In a well-designed
study it was found that
39% of those taking the recommended dosage of APAP had 3 to 8 times the upper
limit for ALT a marker for liver toxicity.
APAP in 2010 caused 56,000
emergency-room visits, 26,000 hospitalizations and 1,600 liver failures,
and this is based on a system designed to grossly underestimate the severity of
the problem. New FDA limits and
warning goes into effect
in 2014. A study of 205,487 children age
6-7 found that the use of APAP is associated with a 323% increase in the risk
of asthma. Four weeks of prenatal use of
APAP is associated with lower motor, cognitive development and more behavioral
problems when compared to a sibling by over 70% for each. Other study found
that APAP during pregnancy
was associated with hyperactivity (ADHD, another with failure to develop testes
(cryptorchidism), and a third with lower masculinization development. The medical
literature on liver toxicity goes
back to the 1960s. Pharma is very good
at controlinge information given to doctors and the public.
Chemotherapy
& Cancer: For
simplicity the discussion is
limited to the most common types of
cancers. Within them are two groups, one with an overall survival of above 50%,
colon, prostate and breast; while for small cell lung and pancreatic cancers
the 5-year survival is less than 5%. If
fatal, it is metastatic--spreads to distant tissues, and chemotherapy is not
curative. The basic question, once diagnosed, is the
prognosis? Several factors are relevant
to estimating how invasive the
cancer is. A biopsy examined under the
microscope that reveals many highly abnormally shaped cells has a high
statistically association with aggressive (fast growing) cancer, but about 40%
are still indolent. Found in 3 local
lymph nodes is associated with metastatic (about 60%), and aggressive (about
80%) of cancers. Distant metastatic
cancer has about a 10% chance of being indolent with about half (5%) living
past 5 years. However, there is no way
to know at stages I through III, if that cancer has become metastatic. If small
colonies have already spread to
distant tissues, removal of the primary tumor does not change the
prognosis. The clock however is running
as to when a cancer will change from indolent or local aggressive to a
metastatic cancer. This change is
through the involvement of stem cells.
The prompt removal of the cancer is the prudently choice to prevent stem
cell involvement. If some indolent
cancer remains, once discovered it can be removed; chemotherapy does not affect
the course of the disease, it just extends life 3 months. Those few with metastatic
cancer who live
several years, do so not because of
an atypical response, but because the cancer is indolent. Without strong proof
that the chemotherapy is
curative, it is not worth taking. Remember
as stated in “Marketing Science”:
the assorted conflicts of interest created
by the role of pharm in research, education, treatment guidelines entail that
the oncologist is a misinformed patient guide.
Also major Positive bias is the norm:
pharma funds clinical trials, owns the
results, write it up, and publish in pharma “friendly” journals.
Cancer basics: cancer is distinguished from a benign tumor by its ability to
invade neighboring
tissue and sometimes spread to distant tissues (metastasize). Also benign
tumors generally have a slower
growth rate and are more differentiated (look like normal cell ). This is the
first area where business has
blurred the distinction between benign and malignant by often calling benign
“carcinoma”; it isn’t unless there is evidence of invasion to adjacent
tissue. Critics have pointed out the
negative consequences of treating benign tumors of the breast prostate, thyroid
cancers, and other tissues chemotherapy following excision or
radiotherapy. Such aggressive treatment
in long-term trials show no benefit or worse.
Benign breast tumors, called “cancer”, when treated with chemotherapy
shorten life over 4.5 years (mostly through the use of an estrogen blocking
drugs and the exclusion of those patents from HRT). In general treating stage
I, II, & III
cancers aggressively with chemotherapy doesn’t change the course of the disease,
but shorten the life of all for who are cancer survivors. The chemotherapy is
pointless because all of
it has been removed by excision. With
the exceptions of a few tissue types, chemotherapy doesn’t cure cancer, but
rather shuts down an essential biological process that affects the rate of cell
reproduction, including in the cancer.
This toxicity limits the chemotherapy.
The average remission (slowing of growth) is 3 months. About half of
the patients will have
long-term side effects. Patients and
physicians believe that the chemo destroys cancer missed by excision, it
doesn’t, and they also believe that those with metastatic cancer who live pass
the average do so because of a typical response to the chemotherapy, but rather
it is because that patient had an indolent (slow growing) cancer. Pharma’s
two deception are to deny indolent
metastatic cancer, and to claim that chemotherapy can destroy for a few
patients the cancer missed by excision.
The oncologists’ greatest source of income is the spread between the
discount price they get the chemo and what they bill. Chemotherapy is thus oversold.
Other Dangerous
Drugs--without
position papers:
A number of different families of
drugs are clearly not worth the side effects for which we have not written a
position paper, yet we are aware of the tenuous evidence and warning issued by
others. We turn to site such as
Worstpill.org, and Cocharanereview.org act as watchdogs. But they are limited
by their sources: they rely upon the FDA and meta-analysis
(combining results of several clinical trials) of the treatments. They choose
their battle and thus repeat the
pharma generated errors on aspirin and hormones. But clinical trials are funded
by pharma and positive bias averages
32%, thus meta-analysis reflect this distortion. Our other sources are
critics of treatments
that are published in medical journal, older medical textbooks. Sometimes we
find a conflict between the
scientific analysis of the condition and the modus operandi (method of action)
of the drugs. Also many on the face of
it are suspect: giving downers to
depressed patients, treating osteoporosis with unnatural chemicals that go to
the bones rather than calcium compounds, attempting to treat a condition with a
drug that doesn’t act upon the underlying cause. A junk drug does more
harm than good, and
often there are clearly better alternatives.
Below is the current list of other junk drugs.
Junk list: Bisphosphonate
for osteoporosis. They increase
the bone density by putting a
compound containing two phosphate groups (P03) in the bones, It isn’t
the same as bone building the
natural way with hydroxyapatite (Ca10(PO4)6(OH)2)
and collagen. Bisphosphonates
don’t prevent fractures long-term and there are side effects. NSAIDs but for
aspirin. They have minimal pain reduction effect, work
well as an anti-inflammatory drug by reducing inflammation, thus their affect
upon pain is minor, as demonstrate by clinical trials. Unfortunately they increase
with long-term usage the incidents of heart
attacks and strokes—from 50% to 400%.
This includes the block buster Celebrex which increases with long-term
usage risk 200%. Psychotropic
drugs used for psychiatric conditions are much worse
than behavioral therapy and worse than no treatment. “When both
published and
unpublished trials are looked at, paroxetine [Paxil] does not appear to be
any better than placebo in adults with moderate or severe depression” Wiki. With only a couple of exceptions
all
psychiatric
drugs are tranquilizers (downers):
hinder cognitive function and cause drowsiness. Since “downer” and “tranquillizer”
have
negative connotations, they all wear different labels for marketing, such as
mood elevator, muscle relaxant, ACE inhibitor, SSRI, etc. Besides used for behavior
issues,
tranquilizers are widely prescribed for physical conditions such as for back
pain, angina, brain trauma, epilepsy, menopausal hot flashes, hypertension, and
so on; even though they don’t affect the core problem and benefits in pharma’s
clinical trials are only slightly better than a placebo. Tranquilizers are spotted
by the side effect
of drowsiness and their indication for psychiatric conditions. FDA approval
is based on 6-week clinical
trial of an ideal population for the goals of the trial—not a real-world
clinical population. By impairing
cognitive function, these drugs do not promote long term behavior improvements
in the general population (no more than alcoholism or marijuana does). They
do not help people deal the underlying
psychiatric behavior problem, In a 2014
population study, “After excluding
deaths in the first year, there were approximately four excess deaths linked to
drug use per 100 people followed for an average of 7.6 years after their first
prescription” BMJ. These
downers by reducing cognitive function
make the patient more dependent upon expert opinion, their doctor and thereby
are associated with polypharmacy; and they shorten life. They negatively affect
quality of life, which
is why there is low compliance.
Treatment of children psychiatric disorders--before the 70’s quite
rare--is unwarranted (with rare exceptions).
Most conditions requiring hospitalization will include a tranquilizer,
protein pump inhibitors (PPI) and
acetaminophen (APAP). Sleep and
cognitive confusion reduces
discussion with staff and thus lightens the work of the care givers, plus they
increases profits. Alzheimer’s
disease (AD), drugs do not affect the course of the
disease. Factoring in the side effects,
they are worse than a placebo. Downers
are often included in treatment of AD,
as if the patient needs more cognitive impairment. Avoid for AD Aricept (donepezil), tranquilizers, & Cognex (tacrine) and
all other drugs given to purportedly slow the progress of AD (they don’t)
or make the patient more manageable. Downers that shorten life and increase
signs
of dementia. Acid reflux condition
(heart burn) should be treated with
over-the-counter antacids; avoid the prescription alternatives, especially
protein pump inhibitors which have rebound effect if stopped which increases
heart burn. There is a lack of effective
drugs for COPD, restless-leg syndrome and many of the minor complaints that are
listed in the Merck Manual, such as fungal infection of the nails. Tamiflu and
other flu medications such as are
junk (see Bad Pharma supra 81-91). Pharma
is very good at making a drug not worth taking appear as safe and
effective.
Pharma is also very good at cooking
up new indications for drugs and having them used off label. Over half the prescriptions
given are for
uses that have not meet the very low FDA hurdle. Most off-label uses have shoddy
marketing
research (phase IV clinical trials), which are used to “educate” doctors.
In general, off-label uses are not in the patient’s
best interest. Doctors have been cast in
the role of drug pushers through clinical guidelines, clinical administrators,
peer pressure, financial rewards from pharma, a lack of reliable information on
treatment alternatives, and continuing educations class given by pharma to name
the main ones. The $600 industry is very
good at marketing.
[1]
The mechanism for pain reduction is through the reduction of inflammation by
blocking only
50% of COX2 & COX1 enzymes and inhibiting the production of
prostaglandins (Goodman & Gilman’s pharmacology textbook 2007 edition, p.
693). This is why they are classified
as
“mild analgesics” (G & G at 681).
Other claims as to medicinal use is at best only weekly supported.
|
|
|
|
Enter supporting content here
INTERNAL SITE SEARCH ENGINE by Google
Looking for a topic, use Google Internal Search
Engine
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Remember that
pharma is in the business of treating illness. There claim of preventing illness is in most cases mere marketing.
Disclaimer: The
information, facts, and opinions provided here is not a substitute for
professional advice. It only indicates
what JK believes, does, or would do. Always
consult your primary care physician for medical advice, diagnosis, and
treatment.
|
|
|